Editorial overview: gastrointestinal: new frontiers in therapeutics for GI diseases and disorders-from microRNAs to novel pharmaceutics, to low FODMAP diets and microbiome
Although cortical volumetric bone mineral density (BMD) and mineral concentration remained unchanged, the findings suggest that GHS treatments can lead to an increase in bone size without necessarily impacting bone density
These shifts are rarely dramatic enough to prompt a doctor's visit but they are consistent, and they are physiological
Additionally, McConkey et al., in 1967, observed the occurrence of transparent skin that was associated with a decrease in dermal collagen in postmenopausal women [21]
Common Mistakes in How Ipamorelin Is Discussed Mistake 01 Treating Selective as a Synonym for Safe The selectivity profile minimal cortisol, prolactin, and appetite effects compared to GHRP-6 is frequently described in community contexts as evidence that Ipamorelin is safe or side-effect free. Selectivity is a pharmacological descriptor of pathway specificity, not a safety determination
